CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-18 | Simpson Robert Arthur SVP/GM, Global Vascular | Grant or award | +4,748 | 17,431 | ||
| 2018-07-18 | Simpson Robert Arthur SVP/GM, Global Vascular | Grant or award · Non-Qualified Stock Option (right to buy) | +15,126 | 15,126 | ||
| 2018-07-18 | Simpson Robert Arthur SVP/GM, Global Vascular | Grant or award · Performance Right | +9,496 | 9,496 | ||
| 2018-07-18 | Trowbridge Stephen A SVP and General Counsel | Grant or award | +4,719 | 37,891 | ||
| 2018-07-18 | Trowbridge Stephen A SVP and General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +15,032 | 15,032 | ||
| 2018-07-18 | Trowbridge Stephen A SVP and General Counsel | Grant or award · Performance Right | +9,437 | 9,437 | ||
| 2018-07-18 | Greiner Michael EVP and CFO | Grant or award | +6,988 | 23,181 | ||
| 2018-07-18 | Greiner Michael EVP and CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +22,260 | 22,260 | ||
| 2018-07-18 | Greiner Michael EVP and CFO | Grant or award · Performance Right | +13,975 | 13,975 | ||
| 2018-07-18 | Clemmer James C President and CEO | Grant or award | +17,469 | 129,286 | ||
| 2018-07-18 | Clemmer James C President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +55,651 | 55,651 | ||
| 2018-07-18 | Clemmer James C President and CEO | Grant or award · Performance Right | +34,938 | 34,938 | ||
| 2018-07-18 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award | +3,539 | 18,036 | ||
| 2018-07-18 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award · Non-Qualified Stock Option (right to buy) | +11,276 | 11,276 | ||
| 2018-07-18 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award · Performance Right | +7,079 | 7,079 | ||
| 2018-07-18 | REED JAN STERN Director | Grant or award | +6,307 | 14,599 | ||
| 2018-07-18 | Meteny Dennis S Director | Grant or award | +6,307 | 80,978 | ||
| 2018-07-18 | LaPorte Steve Director | Grant or award | +6,307 | 48,484 | ||
| 2018-07-18 | JOHNSON WESLEY Director | Grant or award | +6,307 | 58,962 | ||
| 2018-07-18 | Gould Kevin J Director | Grant or award | +6,307 | 55,124 |
Page 29 of 30 · 589 trades